NuMe Health, LLC
To develop & market evidence-based Cobiotic consumer products to manage the bacteria that live in the GI tract to prevent and manage disease
Early 2012 direct-to-consumer launch of its first product based on proprietary NM504 blend, growing to at least 3 category offerings and 8 SKUs by 2014. Internal capabilities will be leveraged by using co-packers and other outside vendors and experts. Using the Internet, print media and social networking, NuMe will begin consumer outreach and education. NuMe products will be supported by targeted clinical data and broad-based academic support.